share_log

健帆生物(300529.SZ):目前各产能建设项目均按计划有序推进

Jafron Biomedical (300529.SZ) : Currently, all production capacity construction projects are being orderly carried out according to plan.

Gelonghui Finance ·  Jun 19 15:31

Jafron Biomedical (300529.SZ) stated on the investor interaction platform on June 19th that all production capacity construction projects of the company are progressing in an orderly manner according to the plan. At present, the company's production capacity can meet the development needs of its business, and the utilization rate of production capacity is in a reasonable range.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment